|
|
Volumn 5, Issue 12, 1996, Pages 1589-1599
|
|
Farnesyl-protein transferase inhibitors in early development
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER;
4 (8 CHLORO 5,6 DIHYDRO 11H BENZO[5,6]CYCLOHEPTA[1,2 B]PYRIDIN 11 YLIDENE) 1 (4 PYRIDYLACETYL)PIPERIDINE;
ANTINEOPLASTIC AGENT;
B 581;
BIPHENYL DERIVATIVE;
BMS 184467;
BMS 185878;
BMS 186511;
BMS 193269;
BZA 2B;
BZA 5B;
DOXORUBICIN;
J 104126;
L 731734;
L 731735;
N (8 AMINO 2 BENZYL 5 ISOPROPYL 9 MERCAPTO 3,6 NONADIENOYL)METHIONINE;
N (8 AMINO 2 BENZYL 5 ISOPROPYL 9 MERCAPTO 3,6 NONADIENOYL)METHIONINE METHYL ESTER;
N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE;
N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE METHYL ESTER;
N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE;
N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER;
PIPERAZINE DERIVATIVE;
PROTEIN FARNESYLTRANSFERASE;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
CARCINOGENESIS;
CELL MEMBRANE;
DRUG DESIGN;
DRUG RESEARCH;
GENETICS;
NONHUMAN;
ONCOGENE RAS;
REVIEW;
|
|
EID: 0030445859
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.12.1589 Document Type: Review |
|
Times cited : (11)
|
|
References (0)
|
